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Keratoconus has been recognized and investigated for 
more than 150 years (1). Historically, ophthalmologists 
have described keratoconus as a bilateral, progressive, 
non-inflammatory disorder of the cornea that is 
associated with corneal steepening and thinning (1,2). 
The Global Panel on Keratoconus and Ectatic Diseases 
recently stated that ‘abnormal posterior ectasia, 
abnormal corneal thickness distribution and clinical non-
inflammatory corneal thinning are mandatory findings to 
diagnose keratoconus (3).’ Nevertheless, it is well 
established that keratoconus is characterized by a 
marked degradation of the corneal extracellular matrix 
involving inflammatory features such as increased levels 
of matrix metallopeptidase 9 (MMP-9), interleukin 6 (IL-
6), and tumor necrosis factor alpha (TNF-αa), as well as 
increased oxidative stress (4,5).  Moreover, patients with 
keratoconus have increased levels of inflammatory 
mediators in their tears, as shown in numerous studies 
(4-7). 
The role of inflammation induced by eye rubbing, 
wearing contact lenses, and ultraviolet irradiation, is 
another aspect of the inflammatory nature of 
keratoconus (4). Eye rubbing is a proven risk factor for 
the development and progression of keratoconus, and it 
involves several pathways, including the stimulation of 
inflammation (8-9).  The complex interactions between 
genetic predisposition and environmental trigger factors, 
(such as eye rubbing and wearing contact lenses) in the 
development of keratoconus probably represents the key 
to understanding the role of inflammation in the 
pathophysiology of keratoconus (10). 
However, there are several enigmatic discrepancies 
impeding our understanding of the proposed 
‘inflammatory model’ of keratoconus. Despite the 
evidence of inflammation accumulated from translational 
and laboratory studies, keratoconic corneas are strikingly 
lacking in the histological and clinical features of 
inflammation, such as cell infiltration and 
neovascularization. Moreover, the coexistence of ocular 
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allergic disease, which is very frequent among patients 
with keratoconus (to different extents in each individual 
patient) (2), potentially masks the true inflammatory 
effect underlying keratoconus, and differentiates its 
phenotype.   
Whether or not the mere presence of inflammatory 
markers in keratoconic corneas is sufficient proof of 
inflammation remains controversial. Could these 
biochemical findings of inflammation represent 
epiphenomena, not primary pathophysiological events? 
Lastly, is it justifiable to classify keratoconus as a quasi-
inflammatory or inflammatory-related condition, as 
suggested by McMonnies? Ongoing research may 
provide tools for further investigation of keratoconus-
related inflammation and future studies may identify 
specific biomarkers that will enhance our understanding 
of the inflammatory condition involved in keratoconus, 
which will elucidate the etiopathological mysteries of 
keratoconus. 
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